Estimation of Off-Label Use of XGEVA® (Denosumab) Using Population-Based Databases in Denmark
Status:
Completed
Trial end date:
2015-02-01
Target enrollment:
Participant gender:
Summary
This study aims to evaluate off-label XGEVA use in Denmark using data linked from registries
and other sources in Northern Jutland Region and Copenhagen. This will allow for accurate
assessment of prescriptions and diagnoses, especially those related to cancer patients during
the first year post the initial market availability of XGEVA.